Evaluation of Rapidly Disintegrating Vaginal Tablets of Tenofovir, Emtricitabine and Their Combination for HIV-1 Prevention

Vaginal tablets are being developed as an alternative to gels as an inexpensive, discreet dosage form for the administration of microbicides. This work describes the pharmacokinetic (PK) evaluation of rapidly disintegrating vaginal tablets containing tenofovir (TFV, 10 mg), emtricitabine (FTC, 10 mg...

Descripción completa

Detalles Bibliográficos
Autores principales: Clark, Meredith R., Peet, M. Melissa, Davis, Sarah, Doncel, Gustavo F., Friend, David R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4279136/
https://www.ncbi.nlm.nih.gov/pubmed/25494201
http://dx.doi.org/10.3390/pharmaceutics6040616

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4279136/
https://www.ncbi.nlm.nih.gov/pubmed/25494201
http://dx.doi.org/10.3390/pharmaceutics6040616

Ejemplares similares